Swipe om te navigeren naar een ander artikel
The use of patient-reported outcome (PRO) measures in clinical practice is increasing. Following the creation of a ‘User’s Guide to Implementing PRO Assessment in Clinical Practice’ by the International Society for Quality of Life Research (ISOQOL), volunteers from ISOQOL sought to create a Companion Guide to assist health care providers with the scientific and practical considerations involved in implementing and using PRO measures in clinical care by using information from real-world case studies. This paper summarizes the key issues presented in the Companion Guide.
Ten respondents, who were members of the ISOQOL’s CP-SIG and worked in various clinical areas, participated in a survey or telephone interview. Participants were from Canada (n = 2), Denmark (n = 1), England (n = 2), Holland (n = 1), and the United States (n = 4).
Based on the information provided by respondents, a Companion Guide was produced, organized according to the nine questions presented in the User’s Guide. An additional section for key take-home messages was also provided. This guide provides examples of issues and considerations related to the implementation of PRO measures in clinical practice.
Respondents provided insight into their experiences and emphasized that PRO initiatives were likely to be more successful if there is purposeful, designed integration into clinical practice, meaningful substantive engagement with all stakeholders and access to necessary organizational resources. The ability to leverage existing technology as well as realistic and stakeholder consensus-driven expectations for planning and timing were also key to the successful implementation of PRO measures.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
International Society for Quality of Life Research. (2015). User’s guide to implementing patient-reported outcomes assessment in clinical practice, version 2. Retrieved March 27, 2018, from http://www.isoqol.org/UserFiles/2015UsersGuide-Version2.pdf.
Guest, G., MacQueen, K. M., & Namey, E. E. (2011). Applied thematic analysis. Thousand Oaks, CA: Sage.
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. (2006). Guidance for industry: patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health Quality of Life Outcomes, 4(1), 79. CrossRef
Committee for Medicinal Products for Human Use. (2005). Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. London: European Medicines Agency.
World Health Organization WH. (2001). International classification of functioning. Disability: ICF. World Health Organization.
- Implementing patient-reported outcome measures in clinical practice: a companion guide to the ISOQOL user’s guide
Eric K. H. Chan
Todd C. Edwards
Sean P. Mikles
- Springer International Publishing